Fig. 1

Characterization of mAbs against 4-CPA. A The UV–vis spectra of the protein, hapten, and artificial antigen. B Purity identification of mAbs, M: marker, 1: reducing gel, 2: non-reducing gel. C Isotype of mAbs. D Sensitivity of mAbs using indirect competitive ELISA (icELISA)